Roivant Sciences Ltd
Follow $ROIV
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ROIV by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ROIV moving today?
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ROIV overview
Related filings and maps
Congress activity in ROIV
No receipt-qualified Congressional disclosure is present for ROIV in the cached public ledger.
ROIV contract awards, year to date.
Public federal awards linked to this ticker.
ROIV lobbying filings, year to date.
Registered lobbying filings matched to Roivant Sciences Ltd.